Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"CD70 CAR"”.

  1. Charakterisierung von AML-Antigenen mit fehlender Expression auf normalen hämatopoetischen Stammzellen für CAR-T-Zell-Therapien

    … dass CD19 und BCMA chimäre Antigen-Rezeptor (CAR)-T-Zell-Therapien nicht nur das Potential haben, die progres¬si-ons¬freie Überlebenszeit von Patienten mit hämatologischen Neoplasien zu verlängern, sondern auch diese erkrankten Menschen in einigen Fällen dauerhaft zu heilen. Trotz der noch …

    wurz-thes Repository record for Charakterisierung von AML-Antigenen mit fehlender Expression auf normalen hämatopoetischen Stammzellen für CAR-T-Zell-Therapien (opens in a new tab)

  2. Targeting Aggressive Brain Tumours With Broadly Cytotoxic Expanded NK And CAR-Engineered NK Cells

    … employed in chimeric antigen receptor (CAR)-based immunotherapies, and have shown significant clinical efficacy against hematologic malignancies. Due to the challenges that arise with CAR-αβ T cells, including manufacturing delays and the potential for fatal immune overactivation, other …

    mcmaster Repository record for Targeting Aggressive Brain Tumours With Broadly Cytotoxic Expanded NK And CAR-Engineered NK Cells (opens in a new tab)

  3. Targeted Biological and Cellular Immunotherapies for Osteosarcoma

    … To circumvent these challenges, we delivered a CD70-specific chimeric antigen receptor (CAR), soluble interleukin 15 (IL-15), and a transforming growth factor beta (TGF-β) dominant negative mutant receptor. These armored CD70-CAR NK cells show remarkable in vitro killing and pro-inflammatory …

    umn Repository record for Targeted Biological and Cellular Immunotherapies for Osteosarcoma (opens in a new tab)

  4. NOVEL IMMUNOTHERAPEUTIC TARGETS IN RECURRENT GLIOBLASTOMA AND BRAIN METASTASIS

    … dismal prognosis and an aggressive standard of care (SoC) involving maximally safe surgical resection, followed by radiotherapy and chemotherapy with temozolomide (TMZ), minimal clinical progress has been made in the past two decades. GBM is characterized by extensive inter- and intra-tumoral …

    mcmaster Repository record for NOVEL IMMUNOTHERAPEUTIC TARGETS IN RECURRENT GLIOBLASTOMA AND BRAIN METASTASIS (opens in a new tab)

  5. Modulating Immunometabolism to Improve The Activity of Car-Nk Cells Targeting Cd70 In Renal Cell Carcinoma

    … therapies for metastatic clear cell renal cell carcinoma (ccRCC), disease resistance and relapse are common, and therapies with novel mechanisms of action are urgently needed. Chimeric antigen receptor (CAR) T-cell therapy has shown remarkable responses in hematologic malignancies, but many …

    uthsc Repository record for Modulating Immunometabolism to Improve The Activity of Car-Nk Cells Targeting Cd70 In Renal Cell Carcinoma (opens in a new tab)